151 related articles for article (PubMed ID: 36705370)
1. Coexistence of primary mediastinal MALT lymphoma and multiple myeloma like POEMS syndrome: A case report and literature review.
Yin S; Zhou K; Wang Z; Gong D; Huang W
Medicine (Baltimore); 2023 Jan; 102(4):e32801. PubMed ID: 36705370
[TBL] [Abstract][Full Text] [Related]
2. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
Yang X; Min X; He W
Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory MALT lymphoma by lenalidomide plus bendamustine: A case report.
Zhou Z; Wu P; Wang F; Tao H; Chen Y; Gao J; Chen D; Jia Y
Medicine (Baltimore); 2022 Mar; 101(9):e28938. PubMed ID: 35244050
[TBL] [Abstract][Full Text] [Related]
4. Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
Knauf W; Abenhardt W; Koenigsmann M; Maintz C; Sandner R; Zahn MO; Schnell R; Tech S; Kaiser-Osterhues A; Houet L; Marschner N;
Hematol Oncol; 2021 Aug; 39(3):313-325. PubMed ID: 33942348
[TBL] [Abstract][Full Text] [Related]
5. Lenalidomide plus rituximab (R
Becnel MR; Nastoupil LJ; Samaniego F; Davis RE; You MJ; Green M; Hagemeister FB; Fanale MA; Fayad LE; Westin JR; Wang M; Oki Y; Forbes SG; Feng L; Neelapu SS; Fowler NH
Br J Haematol; 2019 Jun; 185(5):874-882. PubMed ID: 30919940
[TBL] [Abstract][Full Text] [Related]
6. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
[TBL] [Abstract][Full Text] [Related]
7. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.
Troch M; Kiesewetter B; Dolak W; Jaeger U; Püspök A; Müllauer L; Chott A; Raderer M
Ann Hematol; 2012 May; 91(5):723-728. PubMed ID: 22186828
[TBL] [Abstract][Full Text] [Related]
9. Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab.
Woehrer S; Streubel B; Chott A; Hoffmann M; Raderer M
Leuk Lymphoma; 2005 Nov; 46(11):1645-9. PubMed ID: 16236618
[TBL] [Abstract][Full Text] [Related]
10. Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.
Joshi M; Sheikh H; Abbi K; Long S; Sharma K; Tulchinsky M; Epner E
Ther Adv Hematol; 2012 Oct; 3(5):275-90. PubMed ID: 23616915
[TBL] [Abstract][Full Text] [Related]
11. Primary thymic mucosa-associated lymphoid tissue lymphoma complicated with renal amyloidosis: A first case report.
Chen Q; Du Y; Prince S; Zhang P; Li G; Wang L; Wang W
Medicine (Baltimore); 2020 Mar; 99(13):e19462. PubMed ID: 32221068
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of nodal marginal zone B-cell lymphoma and multiple myeloma: A case report and literature review.
Wang M; Guo Y; Dong L; Bi K
Medicine (Baltimore); 2022 Apr; 101(17):e29219. PubMed ID: 35512080
[TBL] [Abstract][Full Text] [Related]
13. Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma.
Cheah CY; Opat S; Trotman J; Marlton P
Intern Med J; 2019 Sep; 49(9):1070-1080. PubMed ID: 30816618
[TBL] [Abstract][Full Text] [Related]
14. Marginal zone lymphoma of palatine tonsil with prominent plasmacytic differentiation: A CARE-compliant article and review of literature.
Ma S; Jug R; Shen S; Zhang WL; Xu HT; Yang LH
Medicine (Baltimore); 2018 Jan; 97(2):e9648. PubMed ID: 29480878
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial.
Grunenberg A; Kaiser LM; Woelfle S; Schmelzle B; Viardot A; Möller P; Barth TFE; Muche R; Dreyhaupt J; Raderer M; Kiesewetter B; Buske C
BMC Cancer; 2021 Jun; 21(1):749. PubMed ID: 34187401
[TBL] [Abstract][Full Text] [Related]
16. Mucosa-associated lymphoid tissue lymphoma of the thymus associated with Sjögren's syndrome: report of a case.
Kinoshita N; Ashizawa K; Abe K; Yamasaki N; Nakamura A; Tagawa T; Soda H; Nagayasu T; Hayashi T
Surg Today; 2008; 38(5):436-9. PubMed ID: 18560967
[TBL] [Abstract][Full Text] [Related]
17. Minimal change disease: an unusual presentation of marginal zone MALT lymphoma.
Inayat F; Law JK; Myers-Gurevitch PM; Seshan SV; Perlman AS
Clin Nephrol; 2016 Mar; 85(3):184-8. PubMed ID: 26636329
[TBL] [Abstract][Full Text] [Related]
18. Marginal Zone Lymphoma: State-of-the-Art Treatment.
Sindel A; Al-Juhaishi T; Yazbeck V
Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
[TBL] [Abstract][Full Text] [Related]
19. A case of colonic MALT lymphoma with intra-abdominal abscess and lung metastasis: A case report.
Lee K; Lee JW; Jung HR; Park M; Cho KB; Lee JY
Medicine (Baltimore); 2023 Oct; 102(43):e35778. PubMed ID: 37904387
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic features of primary thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type].
Sun L; Shi HY; Wei LX
Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):234-8. PubMed ID: 22800518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]